Search PubMed⌕ Search

Biomedical subjects

R Neville

Publications and source records attributed to R Neville.

34 records · Page 2Linked to original sources
PubMed1986

Preservative cytotoxicity to cultured corneal epithelial cells.

Cultured human and rat corneal epithelial cells with 51Cr incorporated were used as a model to test the cytolytic action of four common preservatives. Benzalkonium chloride, chlorohexidine and thimerosol were all found to lyse greater than 40% cells when incubated for fifteen minutes at concentrations in clinical use in topical ophthalmic medications. Chlorobutanol is the only preservative tested which has a low level of cytotoxicity (10%) and which, under these conditions, can be considered a safe preservative using cytolytic activity as the means of criteria.

Animals↗
PubMed1981

Isolation and partial characterization of pancreatic polypeptide-like material in the brain of the blowfly Calliphora vomitoria.

Using 10(6) flies (5 kg of heads) a pancreatic polypeptide-like material has been partially purified from the blowfly Calliphora vomitoria. The isolated material was eluted on Sephadex G-50 similarly to bovine pancreatic polypeptide and had an RF on polyacrylamide-gel electrophoresis that was identical with that of the bovine hormone. The material diluted linearly and showed parallelism with bovine standards in a bovine pancreatic polypeptide immunoassay. In specificity controls the immunoreactivity was not abolished by trasylol and no cross-reactivity was discerned in assay for glucagon, proangiotensin and cyclic AMP. These data suggest that the pancreatic polypeptide material in the brain of the blowfly has close structural similarity to the mammalian hormone.

Animals↗
PubMedDate not supplied

Distal venous patch improves results in PFTE bypasses to tibial arteries.

In recent years, the management of limb-threatening ischemia has involved the use of distal bypasses to vessels beyond the popliteal trifurcation. Excellent patency rates and limb salvage data are achieved through the use of autologous long saphenous vein. However, an increasing number of patients in need of tibial bypass do not have adequate saphenous vein due to previous procedures, thrombophlebitis, or inadequate vein. In such cases alternative conduits have been proposed including lesser saphenous vein, arm vein, composite veins, composite vein with polytetrafluoroethylene (PTFE), and PTFE with or without a distal arteriovenous fistula. Unfortunately these alternative conduits have not resulted in equivalent results when used for distal bypass to tibial arteries. Several authors have reported upon the use of venous tissue at the distal anastomosis in the form of cuffs, collars, and boots to improve the results of prosthetic grafts in this challenging patient population. These techniques have been proposed as an option for revascularization in patients without adequate saphenous vein in an attempt to obtain limb salvage. The purpose of this review is to examine some of those techniques and focus on distal vein patch configuration with its perceived advantages and drawbacks.

Blood Vessel Prosthesis↗
PubMedDate not supplied

Pyrolytic carbon, porous implants, and the fibrin adhesive system.

The bone implant interface for Pyrolite and titanium alloy was evaluated. The effects of a fibrin adhesive system (FAS) on the interface was also compared. Fixation of the Pyrolite and porous titanium implants was observed to occur in the 4-week period of the study with minimal fibrous tissue encapsulation. The ultimate interfascial shear strength for bone-Pyrolite interface was attained at 4 weeks. No adverse effect with utilization of the FAS could be identified. Further investigation into the use of Pyrolite and the FAS in foot surgery is anticipated.

Animals↗
PubMedDate not supplied

Role of heparin in reducing skeletal muscle infarction in ischemia-reperfusion.

Heparin continues to be recommended in the clinical management of limb ischemia to prevent extension of distal vascular thrombosis and increased rates of limb loss. However, heparin may also be responsible for reduced skeletal muscle injury. Although its mechanism of action has not been fully evaluated, we have investigated the ability of heparin to minimize skeletal muscle injury associated with the ischemia-reperfusion syndrome in an in vivo canine gracilis muscle model. Our findings demonstrated a significant reduction in the amount of skeletal muscle infarction, microvascular permeability, and H+ ion accumulation cumulation after preischemic heparinization. Diffuse intravascular coagulation also has been observed in observed in this model which may be prevented or reduced by the anticoagulant properties of heparin when administered prior to ischemia. However, heparin's protective effect may be independent of its anticoagulant activity. Heparin is a polycomponent drug with non-anticoagulant properties which may serve to reduce cellular injury during ischemia and reperfusion in several different ways. Microvascular injury is decreased by the restoration of normal intimal negative charge and through the binding and resultant inactivation of histamine, bradykinin and other vasoactive amines. Heparin inhibits the complement cascade which is known to determine ischemic infarct size. Other factors of importance in determining the extent of skeletal injury include neutrophil activation, chemotaxis, enzyme release, and free oxygen radical generation, all of which are decreased or modulated by heparin. Heparin is a complex substance and much more remains to be learned about its anticoagulant and nonanticoagulant properties as well as its protective effects on skeletal muscle injury in ischemia-reperfusion syndrome.

Animals↗